4CPS-238 Evaluation of effectiveness of compounded oral vancomycin capsules for treatment of Clostri...
4CPS-238 Evaluation of effectiveness of compounded oral vancomycin capsules for treatment of Clostridium difficile infection
About this item
Full title
Author / Creator
Publisher
London: BMJ Publishing Group LTD
Journal title
Language
English
Formats
Publication information
Publisher
London: BMJ Publishing Group LTD
Subjects
More information
Scope and Contents
Contents
Background and importanceOral vancomycin (125 mg four times daily) is the standard treatment for mild/moderate Clostridium difficile infection (CDI). As there are no marketed vancomycin capsules in our country, vancomycin 500 mg vials have been taken orally for this purpose. But high price, difficult acquisition and complicated dilution and adminis...
Alternative Titles
Full title
4CPS-238 Evaluation of effectiveness of compounded oral vancomycin capsules for treatment of Clostridium difficile infection
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2501407560
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2501407560
Other Identifiers
ISSN
2047-9956
E-ISSN
2047-9964
DOI
10.1136/ejhpharm-2021-eahpconf.70
